120 related articles for article (PubMed ID: 10979448)
1. [Multiresistant Escherichia coli from elderly patients].
Slucky-Shraga I; Wolk M; Volis S; Vulikh I; Sompolinsky D
Harefuah; 2000 Jul; 139(1-2):25-9, 79. PubMed ID: 10979448
[TBL] [Abstract][Full Text] [Related]
2. Integron-mediated ESBL resistance in rare serotypes of Escherichia coli causing infections in an elderly population of Israel.
Sompolinsky D; Nitzan Y; Tetry S; Wolk M; Vulikh I; Kerrn MB; Sandvang D; Hershkovits G; Katcoff DJ
J Antimicrob Chemother; 2005 Jan; 55(1):119-22. PubMed ID: 15574469
[TBL] [Abstract][Full Text] [Related]
3. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
4. Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli.
Sorlózano A; Gutiérrez J; Romero JM; de Dios Luna J; Damas M; Piédrola G
J Basic Microbiol; 2007 Oct; 47(5):413-6. PubMed ID: 17910106
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
[TBL] [Abstract][Full Text] [Related]
6. Endemic occurrence of infections by multidrug-resistant Escherichia coli of four unique serotypes in the elderly population of Israel.
Wolk M; Valinsky L; Sompolinsky D; Sechter I; Schmidt H; Tetry S; Agmon V
FEMS Microbiol Lett; 2004 Oct; 239(2):249-54. PubMed ID: 15476973
[TBL] [Abstract][Full Text] [Related]
7. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Duttaroy B; Mehta S
Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
[TBL] [Abstract][Full Text] [Related]
9. The antimicrobial susceptibility of Escherichia coli isolated in eastern area of Romania. A surveillance study.
Poiată A; Tuchilus C; Bădicut I; Grigore L; Filipiuc S; Adomniţei C; Buiuc D
Roum Arch Microbiol Immunol; 1999; 58(2):177-84. PubMed ID: 11845455
[TBL] [Abstract][Full Text] [Related]
10. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
Bin C; Hui W; Renyuan Z; Yongzhong N; Xiuli X; Yingchun X; Yuanjue Z; Minjun C
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):351-7. PubMed ID: 16934430
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of the frequency of extended spectrum beta-lactamases and antibiotic resistance in clinical isolates of Escherichia coli and Klebsiella sp].
Ekşi F; Ozer G; Balci I
Mikrobiyol Bul; 2007 Jul; 41(3):447-52. PubMed ID: 17933257
[TBL] [Abstract][Full Text] [Related]
13. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
[TBL] [Abstract][Full Text] [Related]
14. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
Odeh R; Kelkar S; Hujer AM; Bonomo RA; Schreckenberger PC; Quinn JP
Clin Infect Dis; 2002 Jul; 35(2):140-5. PubMed ID: 12087519
[TBL] [Abstract][Full Text] [Related]
15. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
Akyar I
Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
[TBL] [Abstract][Full Text] [Related]
16. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
Aykut Arca E; Karabiber N
Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
[TBL] [Abstract][Full Text] [Related]
17. Escherichia coli: development of carbapenem resistance during therapy.
Hong T; Moland ES; Abdalhamid B; Hanson ND; Wang J; Sloan C; Fabian D; Farajallah A; Levine J; Thomson KS
Clin Infect Dis; 2005 May; 40(10):e84-6. PubMed ID: 15844056
[TBL] [Abstract][Full Text] [Related]
18. [Changes of antimicrobial resistance among clinical isolates of Escherichia coil in Shanghai 1990-2004].
Zhang YY; Zhu DM; Hu FP; Wu S; Wang F
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):12-6. PubMed ID: 16606528
[TBL] [Abstract][Full Text] [Related]
19. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of catheter-associated urinary tract infections and multi-drug-resistant Escherichia coli isolates from the urine of dogs with indwelling urinary catheters.
Ogeer-Gyles J; Mathews K; Weese JS; Prescott JF; Boerlin P
J Am Vet Med Assoc; 2006 Nov; 229(10):1584-90. PubMed ID: 17107313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]